Raquel Bono - Humana Independent Director
| HUM Etf | USD 296.38 0.30 0.10% |
| Age | 64 |
| Tenure | 4 years |
| Address | Humana Building, Louisville, KY, United States, 40202 |
| Phone | 502 580 1000 |
| Web | https://www.humana.com |
Raquel Bono Latest Insider Activity
Tracking and analyzing the buying and selling activities of Raquel Bono against Humana etf is an integral part of due diligence when investing in Humana. Raquel Bono insider activity provides valuable insight into whether Humana is net buyers or sellers over its current business cycle. Note, Humana insiders must abide by specific rules, including filing SEC forms every time they buy or sell Humana'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Raquel Bono over two months ago Acquisition by Raquel Bono of tradable shares of Humana subject to Rule 16b-3 |
Humana Management Efficiency
The company has Return on Asset of 0.0401 % which means that on every $100 spent on assets, it made $0.0401 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0784 %, implying that it generated $0.0784 on every 100 dollars invested. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Kenneth Burdick | Centene Corp | 62 | |
| Brian Maddy | Molina Healthcare | N/A | |
| Cynthia Ryan | Cigna Corp | 50 | |
| Jennifer Gilligan | Centene Corp | N/A | |
| David Pollack | Molina Healthcare | N/A | |
| Barbara Brasier | Molina Healthcare | 62 | |
| Laurie Havanec | CVS Health Corp | 63 | |
| Theodore Samuels | Centene Corp | 66 | |
| William DeLaney | Cigna Corp | 65 | |
| D Wilson | UnitedHealth Group Incorporated | 60 | |
| Jonathan Dinesman | Centene Corp | N/A | |
| Sarah London | Centene Corp | 43 | |
| James Barry | UnitedHealth Group Incorporated | 78 | |
| Kathleen Mazzarella | Cigna Corp | 61 | |
| Ashlee Knuckey | Centene Corp | N/A | |
| Jim Murray | Centene Corp | N/A | |
| Alan MD | CVS Health Corp | 62 | |
| Hakan Kardes | Alignment Healthcare LLC | 37 | |
| Supriya Sood | Alignment Healthcare LLC | N/A | |
| Dinesh MD | Alignment Healthcare LLC | 55 | |
| Steven Miller | Cigna Corp | 62 | |
Management Performance
| Return On Equity | 0.0784 | ||||
| Return On Asset | 0.0401 |
Humana Inc Money Managers
| David Jones, Independent Director | ||
| Kurt Hilzinger, Independent Chairman of the Board | ||
| Joseph Ventura, Chief Legal Officer and Corporate Secretary | ||
| Vishal MD, Chief Officer | ||
| Susan Schick, Segment President Group and Military Business | ||
| Raquel Bono, Independent Director | ||
| Jorge Mesquita, Independent Director | ||
| W Dunbar, Independent Director | ||
| David Feinberg, Independent Director | ||
| Cynthia Zipperle, Senior Vice President, Chief Accounting Officer, Controller | ||
| Heather Carroll, Chief Digital Health and Analytics Officer | ||
| Marissa Peterson, Independent Director | ||
| Alan Wheatley, Segment President - Retail | ||
| James MBA, President COO | ||
| Kate Goodrich, Senior Officer | ||
| Timothy Wheatley, Segment Retail | ||
| Christopher Hunter, Segment President, Group and Military Business | ||
| Susan Diamond, Chief Financial Officer, Segment President, Home Business | ||
| Andrew Agwunobi, President - Home Solutions Business | ||
| Heather Cox, Chief Digital Health and Analytics Officer | ||
| Jessica Clark, Senior Improvement | ||
| David Dintenfass, President Growth | ||
| Jennifer Bazante, Chief Marketing Officer | ||
| James OBrien, Independent Director | ||
| Amy Fry, Sr Communications | ||
| John III, Senior President | ||
| Marcy Klevorn, Independent Director | ||
| Nwando Olayiwola, Senior Vice President Chief Health Equity Officer | ||
| William Fleming, Segment President, Pharmacy Solutions and Chief Corporate Affairs Officer | ||
| Vishal Agrawal, Chief Strategy and Corporate Development Officer | ||
| Brian Kane, Chief Financial Officer | ||
| Wayne Frederick, Independent Director | ||
| PharmD PharmD, Chief Solutions | ||
| Bethanie Stein, President Pharmacy | ||
| Frank DAmelio, Independent Director | ||
| Erin Champlin, Senior Experience | ||
| Timothy Huval, Chief Human Resource Officer, Chief Administrative Officer | ||
| Sue Schick, President - Military and Specialty Businesses | ||
| T Wheatley, Segment President - Retail | ||
| Tracy Nolan, Senior MarketPoint | ||
| Sam Deshpande, Chief Technology Officer, Chief Risk Officer | ||
| Bruce Broussard, CEO and President Director and Chairman of Executive Committee | ||
| George II, President Medicaid | ||
| Eric Tagliere, Senior CTO | ||
| Frank Bisignano, Independent Director | ||
| Samir Deshpande, Chief Information Officer | ||
| William Shrank, Chief Medical and Corporate Affairs Officer | ||
| John Garratt, Independent Director | ||
| MD MBA, President CenterWell | ||
| Carolyn Tandy, Senior Vice President and Chief Inclusion and Diversity Officer | ||
| Jay Khosla, Senior Officer | ||
| William McDonald, Independent Director | ||
| JohnPaul Felter, Chief VP | ||
| Lisa Stoner, Vice Relations | ||
| Michael Koeberlein, Senior Vice President Chief Accounting Officer, Controller | ||
| Karen Katz, Independent Director |
Humana Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Humana a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0784 | ||||
| Return On Asset | 0.0401 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 43.59 B | ||||
| Shares Outstanding | 120.41 M | ||||
| Shares Owned By Insiders | 0.21 % | ||||
| Shares Owned By Institutions | 94.78 % | ||||
| Number Of Shares Shorted | 4.55 M | ||||
| Price To Earning | 19.12 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.